17 – 18 april 2020
20th annual
SCANDINAVIAN MEETING
on Parkinson’s Disease and Related Disorders
“From Diagnosis to Management of Parkinson’s disease”
Scandic Holmenkollen Park, Oslo – Norway
PROGRAM
FRIDAY 17 APRIL 2020
11.30-12.25 Lunch and registration 12.25-12.30 Opening of the meeting
12.30-14.00 PathogenesisWhere does PD start?
* Per Borghammer, Denmark
Neurogenetics of PD: Update and clinical relevance
* Thomas Gasser, Germany
Translational approaches to treatment of Parkinson ́s disease
* Mathias Toft, Norway
Symptomatology
14.00-14.30 Motor
Axial disturbances: Camptocormia, Pisa Syndrome, Antecollis, Retrocollis
* Gunther Deuschl, Germany
14.30-15.00 Coffee
15.00-16.00 Non-motor
Comparing and contrasting the motor and non-motor effects of advanced therapies in PD
* Ray Chaudhuri, England
Understanding depression in PD* Murat Emre, Turkey
16.00-17.00 DiagnosticsBiomarker-based early diagnosis of PD
* Miles Trupp, Sweden
Wearables for monitoring PD and its treatments
* Filip Bergqvist, Sweden
17.00-17.15 Coffee
17.15-17.45 Therapy of advanced PDDBS: Latest developments
* Elena Moro, France
17.45-18.45 Best papers
Best 3 experimental papers 2019-20
* Anders Björklund, SwedenBest 3 clinical papers 2019-20
* Andrew Lees, England
18.45-19.15 Pro-Cons Session
Shall we start PD therapy with L-dopa?
* Yes: Espen Dietrichs, Norway
* No: Christian Oehlwein, Germany
20.00 DINNER
SATURDAY 18 APRIL 2020
08.00-10.00 Therapy of advanced PDPump-based therapies for PD: state of the art
* Tove Henriksen, Denmark
Differential Indication for Advanced therapies
* Werner Poewe, Austria
Cognitive decline in PD: Clinical phenotype, imaging and treatment strategies
* Irene Rektorova, Czech Republic
Placebo effects in PD
* Joaquim Ferreira, Portugal
10.00-10.30 Coffee
10.30-11.00 Future treatment
Trophic factor-based therapy: Where are we standing?* Alan Whone, England
11.00-13.00 Non-PD Movement Disorders
MSA: Clinical manifestations and therapeutic options
* Gregor Wenning, Austria
PSP: Clinical manifestations and therapeutic options
* Gunther Höglinger, GermanyTherapeutic options for Dystonia
* Marie Vidailhet, France
Tics and Tourette: Symptomatology and Clinical Management
* Kirsten Muller-Vahl, Germany
13.00-13.30 Lunch and departure
PROGRAM COMMITTEE
Jan Aasly, Norway • Anna, Björnsdottír, Iceland • Espen Dietrichs, Norway • Tove Henriksen, Denmark • Erik Hvid-Danielsen, Denmark • Skirmante Mardosiene, Denmark • Mika Martikainen, Finland • Per Odin, Germany • Sven Pålhagen, Sweden • Gudrun Sigurdardóttir, Iceland • Håkan Widner, Sweden • Markus Wiksten, Finland
The official languages of the symposium will be English and Scandinavian